Risk Factor Guidelines: Smoking

  1. Key Points
  2. AAP GUIDELINES ABOUT SMOKING
  3. Rationale
  4. Quick guide to pharmacotherapy
  5. Quick Guide to Tobacco Treatment
  6. Frequently Asked Questions
    1. 1. What can parents do to prevent their kids from smoking?
    2. 2. How is second-hand smoke bad?
    3. 3. What are bidis and kreteks?
    4. 4. What kind of bad things are in cigarettes?
    5. 5. Can smoking change how I look?
    6. 6. Are low-tar cigarettes better than regular cigarettes?
    7. 7. What about clove cigarettes (kreteks), bidis or cigars? Are they any safer than regular cigarettes?
    8. 8. Is smokeless tobacco or chew bad for your health?
    9. 9. Can smoking affect my ability to play sports?
    10. 10. Why is it so hard to quit smoking?
    11. 11. What are some ways to quit smoking?
    12. 12. Can free telephone counseling be effective?
    13. 13. What kinds of in-person counseling are effective for adolescents?
    14. 14. Does medication increase success in quitting?
    15. 15. What are the first-choice medications?
    16. 16. Are medications appropriate for lighter smokers (e.g., 10-15 cigarettes/day)?
    17. 17. What second-choice medications are recommended
    18. 18. Which medications should be considered with patients particularly concerned about weight gain?
    19. 19. Which medications should be considered with patients with a history of depression?
    20. 20. May tobacco dependence medications be used long-term (e.g., 6 months or more)?
    21. 21. Is combining nicotine replacement medications okay and does it increase rates of success?
  7. Additional information for parents and children
  8. Citations

Key Points

AAP GUIDELINES ABOUT SMOKING[note] (American Academy of Pediatrics. Committee on Substance Abuse 2001) (American Academy of Pediatrics. Committee on Environmental Health 1997)

Rationale

Dangers of Environmental Tobacco Smoke (ETS) exposure

Epidemiology of Childhood Smoking

Factors associated with youth tobacco use

Quick guide to pharmacotherapy

Quick Guide to Tobacco Pharmacotherapies for Child Healthcare Clinicians
Dosing Instructions
Nicotine Replacement Options
Nicotine Patches (OTC) (Generic also available by prescription)
15 mg
21 mg
14 mg
7 mg
Initial 1 patch/16 hours MAX same
Initial 1 patch/24 hours MAX same
Treatment duration: 8 weeks. At the start of each day, place a fresh patch on a relatively hairless area of skin between the waist and neck. If sleep disruption occurrs, the patch may be worn only during waking hrs.
Nicotine Gum (OTC)
2 mg
4 mg
Initial 1 piece/1-2 hrs
MAX 24 pieces/24 hrs
Treatment Duration: 8-12 weeks. Chew gum slowly until the taste of mint or pepper occurs. Then park the gum between the cheek and gum to permit absorbtion through the oral mucosa. Repeat and continue for approx. 30 min. Avoid acidic beverages (coffee, juice, soda) or eating for 15 minutes before and during use.
Nicotine Nasal Spray (prescription)
10 mg/ml Initial 1-2 doses/hr
MAX 5 doses/hr or 40 doses/day
Treatment Duration: 3-6 mos. One spray to each nostril (1 mg total nicotine). Avoid sniffing, inhaling, or swallowing during administration as irritating effects are increased. Tilt the head back slightly during administration.
Inhaler (prescription)
10 mg/cartridge Initial 6-16 cartridges/day
MAX 16 cartridges/day
Treatment Duration: 3-6 mos. Temperature < 40° F decrease nicotine delivery. Avoid acidic beverages or eating for 15 minutes before use.
Lozenge (OTC)
2 mg
4 mg
1 loz/1-2 hrs (wks 1-6)
1 loz 2-4 hrs (wks 7-9>
1 loz 4-8 hrs (wks 10-12)
Treatment Duration 12 wks. Avoid eating/drinking for 15 minutes before use. Suck lozenge until it dissolves. Do not bite, chew, or swallow lozenge.
Non-Nicotine Medication
Bupropion HCL SR (prescription)
150 mg tablet Initial 150 mg/day (days 1-3)
300 mg/day (day 4+)
MAX 300 mg/day
Treatment Duration 7-12 wks. Begin bupropion 1-2 wks before the quit date. Duration of therapy is 7-12 wks and may be extended up to 6 mos.
Please consult the Physician's Desk Reference for comparable product information and contraindications
(Winickoff, JP 2005)

Quick Guide to Tobacco Treatment

Quick Guide to Tobacco Treatment
The 5A's for Child Healthcare Clinicians
Ask about tobacco use at every visit
  • Implement an office system that ensures that, for every patient at every visit, adolescent and parental tobacco use status and secondhand smoke exposure is documented
Advise all tobacco users to quit
  • I strongly advise you to establish a no-smoking policy in your home and car and that you quit smoking yourself. I can help you.
Assess readiness to quit
  • Ask every tobacco user if s/he is willing to make a quit attempt at this time
  • If willing to quit, provide assistance
  • If unwilling to quit, provide motivational intervention. (5 R's: Relevance, Risks, Rewards, Roadblocks, Repetition)
Assist tobacco users in quitting
  • Provide brief counseling
    • Help with a quit plan: Help the smoker set a quit date, if ready. Ask smoker to inform family, friends and coworkers about the intention to quit. Anticipate challenges to quitting. Get rid of cigarettes/ smoking paraphernalia. In the days preceding the quit date, consider changing the pattern of smoking so that the smoker avoids smoking in places that usually trigger the desire for a cigarette.
    • Reasons to quit; Clarify the goal of complete abstinence.
    • Barriers to quitting
    • Lessons from past quit attempts
    • Identify triggers and difficult situations and consider coping strategies
    • Enlist social support: Suggest and help the smoker identify a family member or friend who will be available to support the quit attempt.
  • Prescribe/recommend pharmacotherapy (patch, gum, lozenge, nasal spray, inhaler, bupropion-SR unless contraindicated.
  • Provide supplementary educational materials
Arrange follow-up
  • Enroll smoker in telephone counseling
  • At subsequent visit, review progress. Congratulate any successes.
  • If tobacco use has recurred:
    • Ask for recommitment to total abstinence
    • Review circumstances that caused lapse
    • Use lapse as a learning experience
    • Assess pharmacotherapy use and problems
  • Consider additional referrals
(Winickoff, JP 2005)

Frequently Asked Questions

1. What can parents do to prevent their kids from smoking?

2. How is second-hand smoke bad?

3. What are bidis and kreteks?

Bidis (pronounced "bee-dees") are small, thin hand-rolled cigarettes imported to the United States primarily from India and other Southeast Asian countries. They consist of tobacco wrapped in a tendu or temburni leaf (plants native to Asia), and may be secured with a colorful string at one or both ends. Bidis can be flavored (e.g., chocolate, cherry, and mango) or unflavored. They have higher concentrations of nicotine, tar, and carbon monoxide than conventional cigarettes sold in the United States.

Kreteks (pronounced "cree-techs") are sometimes referred to as clove cigarettes. Imported from Indonesia, kreteks typically contain a mixture consisting of tobacco, cloves, and other additives. As with bidis, standardized machine-smoking analyses indicate that kreteks deliver more nicotine, carbon monoxide, and tar than conventional cigarettes. There is no evidence to indicate that bidis or kreteks are safe alternatives to conventional cigarettes.

4. What kind of bad things are in cigarettes?

5. Can smoking change how I look?

Yes! And not for the better.

6. Are low-tar cigarettes better than regular cigarettes?

No. The risk for lung cancer is only slightly lower with low tar cigarettes. Reduced tar levels have little, if any, effect on other lung diseases or heart disease. Existing research does not support recommending that smokers switch to low-yield cigarette brands. There is no convincing evidence that changes in cigarette design have resulted in an important decrease in the diseases caused by cigarettes. The best thing you can do for your health is to quit now.

7. What about clove cigarettes (kreteks), bidis or cigars? Are they any safer than regular cigarettes?

There is no evidence to indicate that clove cigarettes, bidis or cigars are safe alternatives to conventional cigarettes.

8. Is smokeless tobacco or chew bad for your health?

Smokeless tobacco is a significant health risk and is not a safe substitute for smoking cigarettes.

9. Can smoking affect my ability to play sports?

Yes, smoking really hurts athletic performance. Here's how.

10. Why is it so hard to quit smoking?

Nicotine is the psychoactive drug in tobacco products that produces dependence. Most smokers are dependent on nicotine, and smokeless tobacco use can also lead to nicotine dependence. Nicotine dependence is the most common form of chemical dependence in the United States. Research suggests that nicotine is as addictive as heroin, cocaine, or alcohol. Examples of nicotine withdrawal symptoms include irritability, anxiety, difficulty concentrating, and increased appetite. Quitting tobacco use is difficult and may require multiple attempts, as users often relapse because of withdrawal symptoms. Tobacco dependence is a chronic condition that often requires repeated intervention.

11. What are some ways to quit smoking?

12. Can free telephone counseling be effective?

People who use telephone counseling are twice as likely to quit as people who don't get any counseling. Telephone counselors are trained to help quitters avoid common mistakes that might lead to relapse. Also most states offer some kind of free telephone counseling or a "Quitline" for people seeking to quit smoking. To find a Quitline in your area, call the American Cancer Society at 1-800-ACS-2345.

13. What kinds of in-person counseling are effective for adolescents?

A recent comprehensive review of adolescent smoking cessation programs indicated that classroom programs had the highest cessation rates (17%), followed by computer-based programs (13%) and school-based clinics (12%).

Brief office based interventions, such as videos, in-person counseling, referrals to quitting support and diligent follow-up, can also boost an adolescents chances of quitting.

14. Does medication increase success in quitting?

Yes. Medication almost doubles a person's chances of quitting and quitting for good.

15. What are the first-choice medications?

All five of the FDA-approved medications for smoking cessation are recommended including bupropion SR, nicotine gum, nicotine inhaler, nicotine nasal spray, and the nicotine patch.

But because of the lack of sufficient data to rank-order these five medications, choice of a specific first-line medication must be guided by factors such as clinician familiarity with the medications, contraindications for selected patients, patient preference, previous patient experience with a specific pharmacotherapy (positive or negative), and patient characteristics (e.g., history of depression, concerns about weight gain).

Special consideration should be given before using medication with selected populations: those with medical contraindications, those smoking less than 10 cigarettes/day, pregnant, and adolescent smokers.

16. Are medications appropriate for lighter smokers (e.g., 10-15 cigarettes/day)?

If medication is used with lighter smokers, clinicians should consider reducing the dose of first-line medications.

17. What second-choice medications are recommended

Clonidine and nortriptyline. Consider prescribing these second-choice agents for patients unable to use first-choice medications because of contraindications or for patients for whom first- choice medications are not helpful. Monitor patients for the known side effects of second- choice agents.

18. Which medications should be considered with patients particularly concerned about weight gain?

Bupropion SR and nicotine replacement therapies (NRTs), in particular nicotine gum, have been shown to delay, but not prevent, weight gain.

19. Which medications should be considered with patients with a history of depression?

Bupropion SR and nortriptyline appear to be effective with this population.

20. May tobacco dependence medications be used long-term (e.g., 6 months or more)?

Yes. This approach may be helpful with smokers who report persistent withdrawal symptoms during the course of pharmacotherapy or who desire long-term therapy. A minority of individuals who successfully quit smoking use over-the-counter nicotine replacement medications (gum, nasal spray, inhaler) long-term. The use of these medications long-term does not present a known health risk. Additionally, the FDA has approved the use of bupropion SR for a long-term maintenance indication.

21. Is combining nicotine replacement medications okay and does it increase rates of success?

Yes. There is evidence that combining the nicotine patch with either nicotine gum or nicotine nasal spray increases long-term abstinence rates over those produced by a single form of NRT.

Additional information for parents and children

Health Effects of Smoking Among Young People

Tips for Quitting Smoking

Benefits of quitting

What happens to your body when you quit smoking

Citations

  1. American Academy of Pediatrics. Committee on Substance Abuse (2001). Tobacco's Toll: Implications for the Pediatrician. .
  2. American Academy of Pediatrics. Committee on Environmental Health (1997). Environmental Tobacco Smoke: A Hazard to Children. .
  3. Brown, RA, Lewinsohn, P, Seeley, JR, Wagner, EF (1996). Cigarette smoking, major depression, and other psychiatric disorders among adolescents. .
  4. Centers for Disease Control and Prevention (1998). Youth Risk Behavior Surveillance: United States, 1997. .
  5. Centers for Disease Control and Prevention (1998). Tobacco use among middle and high school students-United States, 2002. .
  6. Centers for Disease Control and Prevention (). You(th) and Tobacco.
  7. Centers for Disease Control and Prevention (). Tips 4 Youth.
  8. Centers for Disease Control and Prevention (). Tobacco Fact Sheets.
  9. Epps, RP, Manley, MW (1993). .
  10. Giovino, GA, Henningfield, JE, Tomar, SL, Escobedo, LG, Slade, J (1995). Epidemiology of tobacco use and dependence. .
  11. Gold, DR, Wang, X, Wypij, D, Speizer, FE, Ware, JH, Dockery, DW (1996). Effects of cigarette smoking on lung function in adolescent boys and girls. .
  12. Groner, JA, Hoshaw-Woodard, S, Koren, G, Klein, J, Castile, R (2005). Screening for Children's Exposure to Environmental Tobacco Smoke in a Pediatric Primary Care Setting. .
  13. Hollis, JF, Polen, MR, Whitlock, EP, Lichtenstein, E, Mullooly, JP, Velicer, WF, et al. (2005). Teen Reach: Outcomes From a Randomized, Controlled Trial of a Tobacco Reduction Program for Teens Seen in Primary Medical Care. .
  14. Johnston, LD, O'Malley, PM, Bachman, JG (). The Monitoring the Future National Survey Results on Adolescent Drug Use: Overview of Key Findings, 2000.
  15. Jackson, C, Henriksen, L, Dickinson, D, Levine, DW (1997). The early use of alcohol and tobacco: its relation to children's competence and parents' behavior. .
  16. Klein, JD (1995646-652). Incorporating effective smoking prevention and cessation counseling into practice. .
  17. Millberger, S, Biederman, J, Faraone, SV, Chen, L, Jones, J (1997). ADHD is associated with early initiation of cigarette smoking in children and adolescents. .
  18. Patton, GC, Carlin, JB, Coffey, C, Wolfe, R, Hibbert, M, Bowes, G (1998). Depression, anxiety, and smoking initiation: a prospective study over 3 years. .
  19. Pbert, L, Moolchan, ET, Muramoto, M, Winickoff, JP, Curry, S, Lando, H, et al. (2003). The State of Office-Based Interventions for Youth Tobacco Use. .
  20. Pirkle, JL, Flegal, KM, Bernert, JT, Brody, DJ, Etzel, RA, Maurer, KR (1996). Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey 1988-1991. .
  21. Pomerleau, OF, Downey, KK, Stelson, FW, Pomerleau, CS (1995). Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. .
  22. Sandler, DP, Everson, RB, Wilcox, AJ, Browder, JP (1985). Cancer risk in adulthood from early life exposure to parents' smoking. .
  23. Substance Abuse and Mental Health Administration (SAMHA) (2003). 2001 National Household Survey on Drug Abuse: Trends in Initiation of Substance Abuse.
  24. Sussman, S (June 6-8, 2001). Effects of Sixty Six Adolescent Tobacco Use Cessation Trials and Seventeen Prospective Studies of Self-Initiated Quitting.
  25. Winickoff, JP, et al (2005). State-of-the-Art Interventions for Office-Based Parental Tobacco Control. .
  26. U.S. Department of Health and Human Services (1994). Preventing Tobacco Use among Young People: A Report of the Surgeon General.
  27. U.S. Department of Health and Human Services (2000). Reducing Tobacco Use: A Report of the Surgeon General.
  28. U.S. Surgeon General (). Clinical Guidelines for Prescribing Pharmacotherapy for Smoking Cessation.

Comments

To find the comment in-context, please follow the provided links.